Segments - Cutaneous Radiation Injury Treatment Market by Treatment (Dressing, Topical, and Oral Drugs), Exposure (Contamination and Irradiation), Stage (Prodromal, Latent, Manifest Illness, Third Wave of Erythema, and Late Effects), Distribution Channels (Online Pharmacy and Offline Pharmacy) and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031
The global cutaneous radiation injury treatment market size was USD XX Bn in 2022 and is likely to reach USD XX Bn by 2031, expanding at a CAGR of XX% during 2023–2031. Increasing prevalence of cancer is expected to drive the market.
Rising number of cancer patients opting for radiation therapy treatment is expected to drive the market. People exposed to harmful radiation are susceptible to developing skin, hair, and nail cancers. These patients require radiation therapy to eradicate the cancerous cells by shrinking cancerous tumors. However, patients are subject to severe skin injuries on different layers of skin. This directly impacts the market, as cutaneous radiation injury treatments provide a holistic treatment for patients to completely recover, quickly. Moreover, growing awareness regarding radiotherapy treatments is expected to drive the market in the coming years. For instance,
According to the report published by the World Health Organization (WHO) on July 27, 2023, about 8.5 million radiotherapy treatments are provided worldwide.
Cutaneous radiation injury treatment helps treat injuries caused by the exposure to harmful radiation. Cancer patients have to go through radiation therapy that uses a high dosage of radiation to shrink the cancerous tumor and destroy the malignant tissue. The treatment causes severe skin irritation, peeling, and damage, as it directly comes in contact with a high dosage of gamma or beta particles passed through the radiation.
At times, people are accidentally exposed to biohazardous radiation in research laboratories, mining, or other such work environments suffer from cutaneous injuries that require treatment with medication and surgeries. Increasing awareness regarding skin treatment alternatives is expected to propel the market.
The COVID-19 pandemic hindered the market due to COVID-19 restrictions, applied by the governments globally. Various critical cancer surgeries were postponed to prevent medical professionals and patients from being exposed to the virus. In the second half of the pandemic, hospitals gradually initiated performing radiation treatments with prior appointments. This helped the market stabilize gradually, throughout the post-pandemic period.
The use of artificial intelligence is likely to provide substantial propulsion to the cutaneous radiation injury treatment market. Incorporating AI-driven technology in generating predictive analytics about the severity of radiation injury for particular patients is an innovative approach to preventive healthcare. AI analyzes patterns; therefore, it plays a pivotal role for patients and as for healthcare providers, by allocating the right resources for them. The rising trend of healthcare automation and increasing demand for preventive healthcare are anticipated to drive the market.
Increasing prevalence of cancer is expected to drive the market. Rapid urbanization and industrialization have led to a rise in exposure of people to carcinogens through food, polluted air, industrial wastes, and alcoholism. These are the key factors that lead to the irradiation or contamination of the body, which causes cancerous tumors in the body. Increasing cancer mortality worldwide is expected to drive the market. For instance,
According to a report published by the WHO, on February 03, 2022, cancer is a leading cause of death worldwide, as the disease claimed the lives of about 10 million people worldwide in 2020.
Lack of skilled professionals is projected to hinder the market. It is important to perform the radiation therapy accurately. The radiation dosage is high, and the slightest mistakes in dose delivery can adversely impact the patient’s health. Therefore, lack of experienced medical professionals is likely to hamper the market during the forecast period.
Studies to enhance the efficiency of cutaneous radiation therapy treatments are expected to create lucrative opportunities in the market. Growing incidences of skin cancer encourage players in the market to enhance the efficiency of the treatment to provide a comprehensive solution to the patients, allowing the scars to heal properly. Therefore, providing customized radiation injury treatment to the patient is expected to provide immense growth opportunities in the market.
The market report includes an assessment of the market trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Cutaneous Radiation Injury Treatment Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2022 |
Historic Data |
2016–2021 |
Forecast Period |
2023–2031 |
Segmentation |
Treatment (Dressing, Topical, and Oral Drugs), Exposure (Contamination and Irradiation), Stage (Prodromal, Latent, Manifest Illness, Third Wave of Erythema, and Late Effects), and Distribution Channels (Online Pharmacy and Offline Pharmacy) |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast |
Key Players Covered in the Report |
3M; Convatec Inc.; Stratpharma AG; Acetech; BMG Pharma spA; Meabco; Intermed S.A; and KeraNetics, Inc. |
Based on treatment, the cutaneous radiation injury treatment market is divided into dressing, topical, and oral drugs. The topical segment is projected to hold a major share of the market during the projection period due to the ease of administration of the drug to the patients. For instance,
According to an article published by the Centers for Disease Control and Prevention (CDC), doctors identify cutaneous radiation injuries (CRIs) when patients develop burn marks on their skin even without being exposed to the radiation directly; however, they are identified to be exposed to certain beta or gamma radiation.
It is easier for healthcare professionals to identify and treat patients with topical medication, as it needs minimum contact with the affected area of patients’ skin. This ease of access is expected to drive the segment in the coming years.
Based on exposure, the global market is segregated into contamination and irradiation. The contamination segment is projected to register a high CAGR during the forecast period due to the increasing alcoholism and tobacco consumption around the world. According to the Union for International Cancer Control, (UICC), people who smoke tobacco and consume alcohol are at a greater risk of developing cancer, and other chronic diseases. Furthermore, increasing alcoholism among the global population is expected to drive the segment in the coming years.
According to a report generated by the WHO on May 9, 2022, rapidly increasing alcoholism is one of the leading causes of cancer among the global population, thereby causing about 13.55 of deaths between 20 years and 39 years of age.
On the basis of stage, the cutaneous radiation injury treatment market is segmented into prodromal, latent, manifest illness, the third wave of erythema, and late effects. The third wave of the erythema segment is anticipated to register robust growth during the forecast period. The patients exposed to the radiation, suffer from severe symptoms such as blistering, intense reddening of skin, and ulceration. The symptoms are severe and they appear in about 10 weeks to 16 weeks of exposure to radiation. Doctors try to treat patients at this stage to prevent further complications caused by the reaction, which is likely to propel the segment during the projection period.
Based on distribution channel, the market is divided into online pharmacy and offline pharmacy. The offline pharmacy segment is expected to generate a major revenue in the coming years due to the established consumer trust in the medicine providers. Such pharmacies are majorly affiliated with the hospitals that treat cancer patients. This reaps immense benefits for the patients as they provide home delivery of medicines, prescription renewals, and discounts. The consumer-centric approach of offline pharmacies is anticipated to drive the segment in the coming years.
In terms of region, the global cutaneous radiation injury treatment market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market owing to the presence of advanced healthcare infrastructure catering to a vast number of patients.
Healthcare organizations in the region are focused on providing holistic patient care for irradiated victims. They efficiently manage the treatment schedule for patients, and take care of the healthcare expenditure for the patients with or without insurance covers. Moreover, increasing prevalence of various types of cancer is expected to drive the market in North America. For instance,
According to a report published in 2021 by the American Cancer Society, cancer caused about 608,570 deaths in the US in 2021, while 19 billion people were diagnosed with cancer the same year.
The market in Asia Pacific is expected to register a rapid growth during the projection period owing to the increasing government investments in cancer studies, research, and treatments. Developing countries such as China and India have progressive healthcare infrastructure and skilled professionals. People from countries in regions such as Africa, travel to Asia to get quality healthcare. For instance,
According to a 2022 report generated by the National Institutes of Health (NIH), India has a significant flow of international patients traveling for cost-effective, quality healthcare services, especially for ailments related to cancer.
Growing number of mining activity and rising number of nuclear power plants in the Asia Pacific increase the chances of people being exposed to harmful radiation, which is likely to drive the market in the region in the coming years.
The Cutaneous Radiation Injury Treatment market has been segmented based on
Key players competing in the global cutaneous radiation injury treatment market are 3M; Convatec Inc.; Stratpharma AG; Acetech; BMG Pharma spA; Meabco; Intermed S.A; and KeraNetics, Inc.
These companies use strategies including mergers, acquisitions, partnerships, collaboration, product launches, and production expansion to get an edge over the competitors. For instance,
On February 6, 2023, KeraNetics, Inc., announced its partnership with ASPN Pharmacies for the fulfillment of the requirement of their prescribed drug, keraStat, a topical drug for the treatment of radiation dermatitis.